Effect of a patient-centered decision app on TOLAC: An RCT

以患者为中心的决策应用程序对 TOLAC 的影响：随机对照试验

• 批准号: 8885864
• 负责人: MIRIAM KUPPERMANN
• 金额: $ 63.74万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-07-10 至 2019-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8885864
• 关键词: Accounting; Address; Benefits and Risks; Birth; Caring; Clinical; Conflict (Psychology); Data; Decision Making; Discipline of obstetrics; Effectiveness; Exercise; Frequencies; Goals; Health; Health Technology; Intervention; Knowledge; Language; Lead; Measures; Neonatal; Outcome; Patient Preferences; Patients; Population; Probability; Provider; Public Health; Randomized; Risk; Role; Trial of Labor; Vaginal Birth after Cesarean; Woman; Work; base; cohort; evidence base; experience; improved; innovation; mHealth; maternal morbidity; patient oriented; preference; pregnant; primary outcome; randomized trial; shared decision making; tool; treatment as usual

DESCRIPTION (provided by applicant): Cesarean delivery (CD) accounts for one-third of all births in the US, representing an increase of approximately 50% in the last decade. Elective repeat CDs (ERCD) are a significant contributor to the rising cesarean rate, resulting from the combination of an increasing rate of primary CD and a decreasing rate of vaginal birth after cesarean (VBAC). A primary driver of the decreased frequency of VBAC is the decline in frequency with which eligible women elect a trial of labor after cesarean (TOLAC). The reasons for this decline are unclear; in particular, little is known about the extent to which patient preferences have contributed to this decrease. In addition, tools to help patients and providers engage in patient-preference driven, shared decision making regarding approach to delivery after cesarean are lacking. We propose to 1) identify patient preference drivers of delivery approach (TOLAC or ERCD) and mode (VBAC or CD) among 240 English- or Spanish-speaking TOLAC-eligible women; 2) use this data to create an innovative, personalized decision support mHealth app (Prior CD Decision App) that integrates values clarification exercises with a validated VBAC prediction tool; and 3) conduct a randomized trial of the Prior CD Decision App versus usual care among 1650 English- or Spanish-speaking women to assess its effect on TOLAC and VBAC rates and decision quality. Our hypotheses are that compared to women who receive only usual care, women who are randomized to use the Prior CD Decision App will be more likely to undergo TOLAC and have a VBAC and will experience less decisional conflict, be more knowledgeable about TOLAC and ERCD and experience more optimal shared decision making.

描述（由申请人提供）：在美国，剖腹产（CD）占所有分娩的三分之一，在过去十年中增加了约50%。选择性重复CD（ERCD）是剖宫产率上升的一个重要因素，这是由于原发性CD率增加和剖宫产后阴道分娩率下降（VBAC）的共同作用。VBAC频率降低的主要驱动因素是符合条件的妇女选择剖腹产后试产（TOLAC）的频率下降。这种下降的原因尚不清楚;特别是，对患者偏好在多大程度上导致这种下降知之甚少。此外，工具，以帮助患者和供应商从事患者偏好驱动，共同决策的方法，剖宫产后分娩是缺乏的。我们建议：1）确定患者偏好的交付方法驱动因素（TOLAC或ERCD）和模式（VBAC或CD）在240名讲英语或西班牙语的TOLAC合格女性中; 2）使用这些数据创建创新的个性化决策支持mHealth应用程序（之前的CD决策应用程序），将价值澄清练习与经验证的VBAC预测工具相结合;和3）在1650名讲英语或西班牙语的女性中进行一项随机试验，比较既往CD决策应用程序与常规护理，以评估其对TOLAC和VBAC率和决策质量的影响。我们的假设是，与仅接受常规护理的女性相比，随机分配使用既往CD决策应用程序的女性更有可能接受TOLAC并进行VBAC，并且会经历更少的决策冲突，对TOLAC和ERCD更了解，并经历更优化的共同决策。